Eli Lilly faces criticism for pay raise
Last year was a bad year for Indianapolis-based pharmaceutical company Eli Lilly. The company faced a continued fall in stock price, government fines and bad publicity. This year looks no better. Last week, Lilly agreed to an $18.5 million settlement with the Arkansas Attorney General’s office over false advertising of the antipsychotic drug Zyprexa.











